Zymeworks
ZYME
67 hedge funds and large institutions have $431M invested in Zymeworks in 2019 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 24 increasing their positions, 6 reducing their positions, and 6 closing their positions.
333% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 6
300% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 6
135% more capital invested
Capital invested by funds: $184M → $431M (+$248M)
54% more call options, than puts
Call options by funds: $1.05M | Put options by funds: $682K
43% more funds holding
Funds holding: 47 → 67 (+20)
14.52% more ownership
Funds ownership: 35.56% → 50.07% (+15%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$32.9M |
| 2 |
Millennium Management
New York
|
+$22.1M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$19.3M |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
+$15.3M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
+$8.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$2.63M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$2.25M |
| 3 |
WCM
Wedge Capital Management
Charlotte,
North Carolina
|
-$2.2M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$2.02M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$902K |
ZYME Hedge Fund Activity: Q2 2019 in Review
67 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q2 2019, worth a combined $431M — up 135% from $184M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ZYME positions and 6 closed out — a net gain of 20 holders — while 24 added to existing stakes and 6 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $32.9M. The largest seller was Rubric Capital Management (New York), exiting entirely with an estimated $2.63M sold.
- 67 institutional investors held Zymeworks (ZYME) as of Q2 2019, up from 47 in Q1 2019.
- Funds reported $431M of Zymeworks stock for Q2 2019, up 135% quarter-over-quarter.
- 26 funds opened new Zymeworks positions in Q2 2019 and 6 closed out, a net change of +20 holders.
- The largest Zymeworks buyer in Q2 2019 was Perceptive Advisors, an estimated $32.9M added.
- The largest Zymeworks seller in Q2 2019 was Rubric Capital Management (New York), an estimated $2.63M sold.
Based on aggregated 13F filings for Q2 2019.